Integrated Filing — IndAS



General information about company

Scrip Code 544014
NSE Symbol HONASA
MSEI Symbol NOTLISTED
ISIN INE0J5401028
Name of company Honasa Consumer Limited
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2026
Date of end of financial year 31-03-2027
Date of board meeting when results were approved 06-11-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 22-10-2026
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Second quarter
Nature of report standalone or consolidated Consolidated
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Unaudited
Segment Reporting Single segment
Description of single segment Beauty and Personal care
Start date and time of board meeting 06-11-2026   12:39:00
End date and time of board meeting 06-11-2026   12:55:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Not applicable



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2026 01-04-2026
B Date of end of reporting period 30-09-2026 30-09-2026
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Consolidated Consolidated
1 Income
Revenue from operations 73,118.70 1,48,713.30
Other income 2,175.50 4,426.60
Total income 75,294.20 1,53,139.90
2 Expenses
(a) Cost of materials consumed 0.00 0.00
(b) Purchases of stock-in-trade 27,419.10 51,443.30
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade (5,438.90) (6,557.90)
(d) Employee benefit expense 7,319.30 13,957.20
(e) Finance costs 316.60 618.80
(f) Depreciation, depletion and amortisation expense 1,097.30 2,146.80
(f) Other Expenses
1 Advertisement expense 24,457.50 48,526.60
2 Other Expenses 10,070.40 21,033.50
Total other expenses 34,527.90 69,560.10
Total expenses 65,241.30 1,31,168.30
3 Total profit before exceptional items and tax 10,052.90 21,971.60
4 Exceptional items 0.00 0.00
5 Total profit before tax 10,052.90 21,971.60
6 Tax expense
7 Current tax 2,834.00 5,688.90
8 Deferred tax (78.80) (54.10)
9 Total tax expenses 2,755.20 5,634.80
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 7,297.70 16,336.80
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 27.10 32.80
16 Total profit (loss) for period 7,324.80 16,369.60
17 Other comprehensive income net of taxes 99.90 73.90
18 Total Comprehensive Income for the period 7,424.70 16,443.50
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent 7,309.80 16,334.70
Total profit or loss, attributable to non-controlling interests 15.00 34.90
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent 7,409.70 16,408.60
Total comprehensive income for the period attributable to owners of parent non-controlling interests 15.00 34.90
21 Details of equity share capital
Paid-up equity share capital 32,602.40 32,602.40
Face value of equity share capital 10 10
27 Details of debt securities
22 Reserves excluding revaluation reserve
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 2.24 5.01
Diluted earnings (loss) per share from continuing operations 2.23 4.99
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 2.24 5.01
Diluted earnings (loss) per share from continuing and discontinued operations 2.23 4.99
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results Textual Information(1)



Disclosure of notes on financial results

Textual Information(1) Notes to the Unaudited Consolidated Financial Results for the quarter and six months ended September 30, 2026 1. The above Unaudited Consolidated Financial Results of Honasa Consumer Limited (the 'Holding Company' or 'the Company') together with its subsidiaries (collectively the 'Group') and joint venture have been prepared in accordance with the recognition and measurement principles laid down in the applicable Indian Accounting Standards ('Ind AS') as prescribed under Section 133 of the Companies Act, 2013, as amended, read with relevant rules thereunder and in terms of the Regulation 33 of the Securities and Exchange Board of India ('SEBI') (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. These Unaudited Consolidated Financial Results have been reviewed by the Audit Committee and approved by the Board of Directors at their respective meetings held on November 06, 2026. 2. During the year ended March 31, 2024, the Holding Company had completed its Initial Public Offer (IPO) of 52,515,692 equity shares of face value of Rs. 10 each at an issue price of Rs. 324 per share (including a share premium of Rs. 314 per share). A discount of Rs. 30 per share was offered to eligible employees bidding in the employee reservation portion of 22,678 equity shares. The issue comprised a fresh issue of 11,267,530 equity shares aggregating to Rs. 3,650 million and offer for sale of 41,248,162 equity shares by selling shareholders aggregating to Rs. 13,364.40 million. Pursuant to the IPO, the equity shares of the Holding Company were listed on National Stock Exchange of India Limited (NSE) and BSE Limited (BSE) on November 07, 2023. The utilisation of the IPO proceeds from fresh issue of Rs. 3,504.92 million (net of IPO expenses of Rs. 145.08 million) is summarized below: Amount to be utilised as per Prospectus (INR Millions) Advertisement expenses towards enhancing the awareness and visibility of brands : 1820 Capital expenditure to be incurred by the Company for setting up new EBOs : 206 Investment in Subsidiary, BBlunt for setting up new salons : 260 General corporate purposes and unidentified inorganic acquisition : 1218.92 Total : 3504.92 Utilisation upto September 30, 2026 (INR Millions) Advertisement expenses towards enhancing the awareness and visibility of brands : 1820 Capital expenditure to be incurred by the Company for setting up new EBOs : 93.51 Investment in Subsidiary, BBlunt for setting up new salons : 93.66 General corporate purposes and unidentified inorganic acquisition : 1218.92 Total : 3226.09 3. The Group is principally engaged in trading of variety of beauty and personal care products and related services with products across baby care, skin care, hair and other related personal care categories which are manufactured through third party contract manufacturers. Accordingly, these, in the context of Ind AS 108 on operating segments reporting are considered to constitute one segment by the Chief Operating Decision Maker and hence the Group has not made any additional segment disclosures. 4. Figures for Unaudited standalone financial results of the Holding Company are as follows: Quarter ended September 30, 2026 (INR Millions) (Unaudited) Revenue from operations : 6894 Profit before tax : 976.41 Profit after tax : 717.01 Quarter ended June 30, 2026 (INR Millions) (Unaudited) Revenue from operations : 6963.18 Profit before tax : 1112.46 Profit after tax : 843.12 Quarter ended September 30, 2025 (INR Millions) (Unaudited) Revenue from operations : 5266.94 Profit before tax : 514.67 Profit after tax : 383.47 Six months ended September 30, 2026 (INR Millions) (Unaudited) Revenue from operations : 13857.18 Profit before tax : 2088.87 Profit after tax : 1560.13 Six months ended September 30, 2025 (INR Millions) (Unaudited) Revenue from operations : 11103.22 Profit before tax : 1052.91 Profit after tax : 782.48 Year ended March 31, 2026 (INR Millions) (Audited) Revenue from operations : 23054.12 Profit before tax : 2447.09 Profit after tax : 1908.27 5. RSM General Trading LLC (RSM), an overseas distributor of the Holding Company, had initiated proceedings in the UAE alleging wrongful termination of the Distributorship Agreement and claiming damages of AED 45 million. The UAE Court initially awarded AED 25.07 million plus interest in favour of RSM. Following various appeals and challenges, the Dubai Court of Cassation (the Highest Court of Dubai, UAE), on July 29, 2026, upheld the Court of Appeal judgment limiting the compensation payable by the Holding Company to AED 1.75 million (Rs. 42.75 million). Separately, the Holding Company initiated proceedings before the Delhi High Court seeking an anti-suit and enforcement injunction against RSM. The matter was subsequently referred to arbitration in accordance with the dispute resolution provisions of the agreement. The arbitral tribunal, through its award dated May 14, 2026, as amended on June 26, 2026, held, inter alia, that the termination of the agreement by the Holding Company was valid, restrained RSM from pursuing proceedings before the Dubai Courts, and directed RSM to pay the Holding Company AED 9.92 million (INR 255.36 million) along with applicable post-award interest. The award further requires RSM to compensate the Holding Company for any amounts sought to be recovered pursuant to decisions of the Dubai Courts relating to termination of the agreement. RSM's right to challenge the Award expired on October 25, 2026. The Holding Company is seeking legal advice from its counsels on the potential enforcement of the Award and the remedies available to it under law. Accordingly, based on the above, the Holding Company does not expect any material financial impact as on date. 6. During the six months ended September 30, 2026, the Holding Company granted 574,400 options to employees under Employee stock options plan 2018, as approved by the Nomination and Remuneration Committee of the Holding Company. During the six months ended September 30, 2026, the paid-up equity share capital of the Holding Company has increased from Rs. 3,253.70 million to Rs. 3,260.24 million pursuant to allotment of 654,422 equity shares on exercise of stock options by employees. 7. On November 21, 2025, the Government of India notified the Code on Wages, 2019, the Code on Social Security, 2020, the Industrial Relations Code, 2020 and the Occupational Safety, Health and Working Conditions Code, 2020 (collectively referred to as the Labour Codes). The Labour Codes consolidate various existing labour laws and introduce changes, including a harmonised definition of wages, which impacts the computation of employee benefit obligations such as gratuity and compensated absences. Based on the information currently available and the guidance issued by the Institute of Chartered Accountants of India, the Group has evaluated the impact of these changes and recognised an incremental cost of Rs. 47.97 million as past service cost as an exceptional item for the year ended March 31, 2026. The Group continues to monitor developments relating to the Labour Codes and will assess the impact, if any, on the measurement of employee benefit liabilities in future periods. 8. The Board of Directors of the Holding Company, at its meeting held on May 21, 2026, had recommended a final dividend of Rs. 3/- per equity share of face value of Rs. 10/- each for the financial year 2025-26, which was approved by the shareholders of the Holding Company at the 10th Annual General Meeting held on September 28, 2026. Accordingly, the dividend aggregating Rs. 978.07 million has been recognised as a distribution to equity shareholders of the Holding Company during the quarter and six months ended September 30, 2026. 9. The Board of Directors of the Holding Company, at its meeting held on June 23, 2026, had approved the proposed acquisition of 58% equity stake of Fluence Pharma Private Limited (Fluence Pharma), subject to closing adjustments and completion of conditions precedent, with the remaining 42% equity stake to be acquired in two tranches over the next 5-7 years from completion of acquisition of the aforesaid stake. Subsequently, on August 25, 2026, the Holding Company called off the proposed acquisition due to non-fulfilment of the closing conditions specified under the Share Purchase Agreement executed between the Holding Company and Fluence Pharma. 10. Subsequent to the quarter and six months ended September 30, 2026, the Board of Directors of Bhabani Blunt Hair Dressing Private Limited (BBlunt), a wholly owned subsidiary of the Holding Company and B:Blunt-Spratt Hairdressing Private Limited (B:Blunt Spratt), a step-down wholly owned subsidiary of the Holding Company, have approved the draft Scheme of Amalgamation (Scheme) of B:Blunt Spratt with and into and BBlunt as per section 233 of the Companies Act, 2013 read with the Companies (Compromises, Arrangements and Amalgamations) Rules, 2016 (including any amendment thereto or re-enactment thereof) and other applicable provisions of the Companies Act, 2013. The Scheme is subject to requisite statutory and regulatory approvals. 11. The Board of Directors of the Holding Company, at its meeting held on June 23, 2026, had approved the incorporation of a wholly owned subsidiary, Honasa Health Private Limited (Honasa Health), to undertake the business-to-consumer (B2C) operations of the Group's nutraceuticals business. During the quarter ended September 30, 2026, Honasa Health was incorporated on July 7, 2026, and the Holding Company has subscribed to 10,000 equity shares of Rs. 10 each aggregating to Rs. 0.1 million.



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2026
Date of end of reporting period 30-09-2026
Whether results are audited or unaudited Unaudited
Nature of report standalone or consolidated Consolidated
Assets
1 Non-current assets
Property, plant and equipment 12,602.50
Capital work-in-progress
Investment property
Goodwill 17,246.50
Other intangible assets 17,990.70
Intangible assets under development
Biological assets other than bearer plants
Investments accounted for using equity method 1,018.50
Non-current financial assets
Non-current investments 1,039.90
Trade receivables, non-current
Loans, non-current 0.00
Other non-current financial assets
1 Security deposits 818.10
2 Fixed deposit with maturity of more than 12 months 41,082.00
3 Interest accrued 3,720.30
Total of other non-current financial assets 45,620.40
Total non-current financial assets 46,660.30
Deferred tax assets (net) 1,156.20
Other non-current assets
1 Capital Advances 125.70
2 Income Tax Asset 532.20
Total of other non-current assets 657.90
Total non-current assets 97,332.60
2 Current assets
Inventories 23,199.40
Current financial asset
Current investments 33,759.80
Trade receivables, current 23,907.90
Cash and cash equivalents 11,886.00
Bank balance other than cash and cash equivalents 2,942.50
Loans, current 0.00
Other current financial assets
Total of other current financial assets 29,761.00
Total current financial assets 1,02,257.20
Current tax assets (net)
Other current assets
1 Balance with government authorities 5,822.60
2 Prepaid expenses 639.60
3 Advance to suppliers 1,052.00
4 Right to receive inventory on provision for sales return net of provision 479.00
5 Advance to employees 60.20
Total of other current assets 8,053.40
Total current assets 1,33,510.00
3 Non-current assets classified as held for sale 0.00
4 Regulatory deferral account debit balances and related deferred tax Assets 0.00
Total assets 2,30,842.60
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 32,602.40
Other equity 1,15,997.20
Total equity attributable to owners of parent 1,48,599.60
Non controlling interest
Total equity 1,48,599.60
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 0.00
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises 0.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 0.00
Total Trade payable 0.00
Other non-current financial liabilities
1 Lease Liabilities 9,645.30
2 Security deposits 23.40
Total of other non-current financial liabilities 9,668.70
Total non-current financial liabilities 9,668.70
Provisions, non-current 1,302.50
Deferred tax liabilities (net) 1.00
Deferred government grants, Non-current
Other non-current liabilities
Total of other non-current liabilities
Total non-current liabilities 10,972.20
Current liabilities
Current financial liabilities
Borrowings, current 0.00
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 4,394.40
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 38,206.50
Total Trade payable 42,600.90
Other current financial liabilities
1 Lease Liabilities 3,226.00
2 Employee benefits payable 2,277.20
3 Payable for capital goods, security deposits and others 190.90
4 Non Controlling Interest Liabilities 1,200.00
5 Dividend payable 8,884.00
Total of other current financial liabilities 15,778.10
Total current financial liabilities 58,379.00
Other current liabilities 5,467.50
1 Statutory dues payable 1,838.10
2 Advance from customers 443.90
3 Provision for sales return 2,997.70
4 Deferred revenue 176.50
5 Deferred income liability 11.30
Total of other current liabilities 5,467.50
Provisions, current 1,076.70
Current tax liabilities (Net) 6,347.60
Deferred government grants, Current
Total current liabilities 71,270.80
3 Liabilities directly associated with assets in disposal group classified as held for sale 0.00
4 Regulatory deferral account credit balances and related deferred tax liability 0.00
Total liabilities 82,243.00
Total equity and liabilites 2,30,842.60
Disclosure of notes on assets and liabilities



Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-07-2026 01-04-2026
Date of end of reporting period 30-09-2026 30-09-2026
Whether results are audited or unaudited Unaudited Unaudited
Nature of report standalone or consolidated Consolidated Consolidated
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2026 01-04-2026
B Date of end of reporting period 30-09-2026 30-09-2026
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Consolidated Consolidated
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Re-measurement gains/(losses) on defined benefit plans 155.50 101.80
2 Share of other comprehensive (loss) of a joint venture (0.10) (0.20)
Total Amount of items that will not be reclassified to profit and loss 155.40 101.60
2 Income tax relating to items that will not be reclassified to profit or loss 39.10 25.60
3 Amount of items that will be reclassified to profit and loss
1 Net exchange gain /(loss) on translation of foreign operations (16.40) (2.10)
Total Amount of items that will be reclassified to profit and loss (16.40) (2.10)
4 Income tax relating to items that will be reclassified to profit or loss 0.00 0.00
5 Total Other comprehensive income 99.90 73.90



Cash flow statement, indirect

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2026
B Date of end of reporting period 30-09-2026
C Whether results are audited or unaudited Unaudited
D Nature of report standalone or consolidated Consolidated
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 21,971.60
Adjustments for reconcile profit (loss)
Adjustments for finance costs 618.80
Adjustments for decrease (increase) in inventories (6,624.10)
Adjustments for decrease (increase) in trade receivables, current (4,619.50)
Adjustments for decrease (increase) in trade receivables, non-current 0.00
Adjustments for decrease (increase) in other current assets (427.20)
Adjustments for decrease (increase) in other non-current assets 0.00
Adjustments for other financial assets, non-current 0.00
Adjustments for other financial assets, current (27.80)
Adjustments for other bank balances 0.00
Adjustments for increase (decrease) in trade payables, current 4,832.40
Adjustments for increase (decrease) in trade payables, non-current 0.00
Adjustments for increase (decrease) in other current liabilities (831.90)
Adjustments for increase (decrease) in other non-current liabilities 0.00
Adjustments for depreciation and amortisation expense 2,146.80
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0.00
Adjustments for provisions, current 0.00
Adjustments for provisions, non-current 257.30
Adjustments for other financial liabilities, current (1,122.80)
Adjustments for other financial liabilities, non-current 0.00
Adjustments for unrealised foreign exchange losses gains 37.10
Adjustments for dividend income 0.00
Adjustments for interest income 2,869.40
Adjustments for share-based payments 361.40
Adjustments for fair value losses (gains) (792.10)
Adjustments for undistributed profits of associates 0.00
Other adjustments for which cash effects are investing or financing cash flow (682.60)
Other adjustments to reconcile profit (loss) 0.00
Other adjustments for non-cash items 890.30
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0.00
Total adjustments for reconcile profit (loss) (8,853.30)
Net cash flows from (used in) operations 13,118.30
Dividends received 0.00
Interest paid 0.00
Interest received 0.00
Income taxes paid (refund) 3,829.80
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) operating activities 9,288.50
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0.00
Cash flows used in obtaining control of subsidiaries or other businesses 0.00
Other cash receipts from sales of equity or debt instruments of other entities 0.00
Other cash payments to acquire equity or debt instruments of other entities 0.00
Other cash receipts from sales of interests in joint ventures 0.00
Other cash payments to acquire interests in joint ventures 0.00
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0.00
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0.00
Proceeds from sales of property, plant and equipment 17.30
Purchase of property, plant and equipment 473.50
Proceeds from sales of investment property 0.00
Purchase of investment property 0.00
Proceeds from sales of intangible assets 0.00
Purchase of intangible assets 0.80
Proceeds from sales of intangible assets under development 0.00
Purchase of intangible assets under development 0.00
Proceeds from sales of goodwill 0.00
Purchase of goodwill 0.00
Proceeds from biological assets other than bearer plants 0.00
Purchase of biological assets other than bearer plants 0.00
Proceeds from government grants 0.00
Proceeds from sales of other long-term assets 21,150.00
Purchase of other long-term assets 29,520.90
Cash advances and loans made to other parties 0.00
Cash receipts from repayment of advances and loans made to other parties 0.00
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0.00
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0.00
Dividends received 0.00
Interest received 985.80
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) investing activities (7,842.10)
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0.00
Payments from changes in ownership interests in subsidiaries 0.00
Proceeds from issuing shares 508.60
Proceeds from issuing other equity instruments 0.00
Payments to acquire or redeem entity's shares 0.00
Payments of other equity instruments 0.00
Proceeds from exercise of stock options 0.00
Proceeds from issuing debentures notes bonds etc 0.00
Proceeds from borrowings 0.00
Repayments of borrowings 0.00
Payments of lease liabilities 1,946.80
Dividends paid 0.00
Interest paid 48.30
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) financing activities (1,486.50)
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes (40.10)
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 3.70
Net increase (decrease) in cash and cash equivalents (36.40)
Cash and cash equivalents cash flow statement at beginning of period 11,922.40
Cash and cash equivalents cash flow statement at end of period 11,886.00